Neuroone Medical Technologies is trading at $2.72 (-5.56%) today as the stock continues to face pressure following recent insider activity.
- Director Mark Christianson reported a 10,000-share sale on June 30, which has contributed to the ongoing downward momentum.
- The stock has experienced increased volatility following its recent inclusion in the Russell Microcap Index.
- No new company-specific announcements or catalysts have been identified for the July 13 trading session.